FDA upgrades recalled broccoli to highest level

AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...
The Trump administration’s overarching message to the legions of people powering the federal government is simple: Leave.
A device long used by adults to manage migraines was now available for children as young as eight years old, offering new ...
The U.S. Food and Drug Administration has labeled the broccoli recall as a Class I, the highest risk level issued by the ...
Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...
It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.
The number of hospitalizations and deaths from foodborne illness doubled last year compared to 2023 in the U.S.
The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
The update is meant “to ensure that cat and dog food manufacturers are aware of information about the new H5N1 hazard ...